CareCloud (CCLD) 10-Q 12 Aug 15 2015 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Jun. 30, 2015	Aug. 06, 2015
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2015
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	Q2
Entity Registrant Name	MEDICAL TRANSCRIPTION BILLING, CORP
Entity Central Index Key	1,582,982
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Trading Symbol	MTBC
Entity Common Stock, Shares Outstanding		11,024,503

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Jun. 30, 2015	Dec. 31, 2014
CURRENT ASSETS:
Cash	$ 632,032	$ 1,048,660
Accounts receivable - net of allowance for doubtful accounts of $197,000 and $165,000 at June 30, 2015 and December 31, 2014, respectively	2,636,879	3,007,314
Current assets - related party	24,284	24,284
Prepaid expenses	178,669	315,901
Other current assets	202,110	188,541
Total current assets	3,673,974	4,584,700
PROPERTY AND EQUIPMENT - Net	1,450,090	1,444,334
INTANGIBLE ASSETS - Net	6,289,676	8,377,837
GOODWILL	8,560,336	8,560,336
OTHER ASSETS	179,208	140,053
TOTAL ASSETS	20,153,284	23,107,260
CURRENT LIABILITIES:
Accounts payable	664,739	1,082,342
Accrued compensation	737,386	836,525
Accrued expenses	935,998	1,113,108
Deferred rent	22,309	12,683
Deferred revenue	24,201	37,508
Accrued liability to related party	38,170	153,931
Borrowings under line of credit	3,000,000	1,215,000
Note payable - related party (current portion)	0	470,089
Notes payable - other (current portion)	130,209	596,616
Contingent consideration	1,843,387	2,626,323
Total current liabilities	7,396,399	8,144,125
Note payable - related party	470,089	0
Notes payable - other	64,091	48,564
DEFERRED RENT	524,565	551,343
DEFERRED REVENUE	38,462	42,631
Total liabilities	$ 8,493,606	$ 8,786,663
COMMITMENTS AND CONTINGENCIES (Note 8)
SHAREHOLDERS' EQUITY:
Preferred stock, par value $0.001 per share; authorized 1,000,000 shares; issued and outstanding none at June 30, 2015 and December 31, 2014	$ 0	$ 0
Common stock, $0.001 par value - authorized, 19,000,000 shares; issued and outstanding, 9,721,974 and 9,711,604 shares at June 30, 2015 and December 31, 2014, respectively	9,722	9,712
Additional paid-in capital	19,059,830	18,979,976
Accumulated deficit	(7,113,417)	(4,460,129)
Accumulated other comprehensive loss	(296,457)	(208,962)
Total shareholders' equity	11,659,678	14,320,597
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$ 20,153,284	$ 23,107,260

CONDENSED CONSOLIDATED BALANCE3

CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Allowance for Doubtful Accounts Receivable (in dollars)	$ 197,000	$ 165,000
Preferred Stock, Par Value (in dollars per share)	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	1,000,000	1,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, Par Value (in dollars per share)	$ 0.001	$ 0.001
Common Stock, Shares Authorized	19,000,000	19,000,000
Common Stock, Shares, Issued	9,721,974	9,711,604
Common Stock, Shares, Outstanding	9,721,974	9,711,604

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
NET REVENUE	$ 5,966,204	$ 2,612,202	$ 12,104,063	$ 5,185,679
OPERATING EXPENSES:
Direct operating costs	2,913,470	1,111,691	6,459,678	2,264,326
Selling and marketing	97,002	44,837	217,433	114,858
General and administrative	3,176,712	1,447,083	6,319,384	2,733,359
Research and development	165,248	126,113	330,175	242,541
Change in contingent consideration	(87,054)	0	(915,815)	0
Depreciation and amortization	1,202,381	271,078	2,361,924	541,121
Total operating expenses	7,467,759	3,000,802	14,772,779	5,896,205
Operating loss	(1,501,555)	(388,600)	(2,668,716)	(710,526)
OTHER:
Interest income	7,073	4,116	13,986	7,105
Interest expense	(43,687)	(51,448)	(85,872)	(104,161)
Other income - net	57,213	17,731	103,359	(182,154)
LOSS BEFORE INCOME TAXES	(1,480,956)	(418,201)	(2,637,243)	(989,736)
INCOME TAX PROVISION (BENEFIT)	6,422	(128,800)	16,045	(316,663)
NET LOSS	$ (1,487,378)	$ (289,401)	$ (2,653,288)	$ (673,073)
NET LOSS PER SHARE:
Basic and diluted loss per share (in dollars per share)	$ (0.15)	$ (0.06)	$ (0.27)	$ (0.13)
Weighted-average basic and diluted shares outstanding (in shares)	9,719,858	5,101,770	9,703,568	5,101,770

CONDENSED CONSOLIDATED STATEME5

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)		3 Months Ended		6 Months Ended
		Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
NET LOSS		$ (1,487,378)	$ (289,401)	$ (2,653,288)	$ (673,073)
OTHER COMPREHENSIVE LOSS, NET OF TAX
Foreign currency translation adjustment (a)	[1]	267,811	(13,800)	(87,495)	117,029
COMPREHENSIVE LOSS		$ (1,219,567)	$ (303,201)	$ (2,740,783)	$ (556,044)
[1]	Net of taxes of $7,105 and $60,288 for the three and six months ended June 30, 2014, respectively. No tax effect has been recorded in 2015 as the Company recorded a valuation allowance against the tax benefit from its foreign currency translation adjustment.

CONDENSED CONSOLIDATED STATEME6

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS [Parenthetical] - Jun. 30, 2014 - USD ($)	Total	Total
Other Comprehensive Loss, Foreign Currency Translation Adjustment, Tax	$ 7,105	$ 60,288

CONDENSED CONSOLIDATED STATEME7

CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY - 6 months ended Jun. 30, 2015 - USD ($)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Loss [Member]
Balance at Dec. 31, 2014	$ 14,320,597	$ 9,712	$ 18,979,976	$ (4,460,129)	$ (208,962)
Balance (in shares) at Dec. 31, 2014		9,711,604
Net loss	(2,653,288)	$ 0	0	(2,653,288)	0
Foreign currency translation adjustment	(87,495)	0	0	0	(87,495)
Forfeiture of shares issued to acquired businesses	(132,880)	$ (54)	(132,826)	0	0
Forfeiture of shares issued to acquired businesses (in shares)		(53,797)
Restrcited share units vested	0	$ 64	(64)	0	0
Restrcited share units vested (in shares)		64,167
Stock-based compensation expense	212,744	$ 0	212,744	0	0
Balance at Jun. 30, 2015	$ 11,659,678	$ 9,722	$ 19,059,830	$ (7,113,417)	$ (296,457)
Balance (in shares) at Jun. 30, 2015		9,721,974

CONDENSED CONSOLIDATED STATEME8

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
OPERATING ACTIVITIES:
Net loss	$ (2,653,288)	$ (673,073)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	2,361,924	541,121
Deferred rent	(5,200)	4,277
Deferred revenue	(17,476)	(22,563)
Deferred income taxes	0	(320,507)
Provision for doubtful accounts	68,872	34,810
Foreign exchange (gain) loss	(86,446)	221,554
Gain from reduction in referral fee	0	(105,523)
Interest accretion on convertible promissory note	0	23,534
Stock-based compensation expense	324,258	62,154
Change in contingent consideration	(915,815)	0
Accrued CastleRock settlement payment	(110,000)	0
Other	0	1,921
Changes in operating assets and liabilities:
Accounts receivable	301,567	185,442
Other assets	80,942	(60,233)
Accounts payable and other liabilities	(802,063)	208,949
Net cash (used in) provided by operating activities	(1,452,725)	101,863
INVESTING ACTIVITIES:
Capital expenditures	(201,945)	(102,325)
Acquisition of customer contracts and relationships	(59,358)	0
Advances to majority shareholder	0	(2,522)
Repayment of advances to majority shareholder	0	1,000
Net cash used in investing activities	(261,303)	(103,847)
FINANCING ACTIVITIES:
Proceeds from note payable to majority shareholder	0	165,000
Repayments of note payable to majority shareholder	0	(115,000)
Repayments of notes payable - other	(486,180)	(600,246)
Proceeds from line of credit	5,856,810	1,485,000
Repayments of line of credit	(4,071,810)	(1,285,000)
IPO-related costs	0	(96,542)
Net cash provided by (used in) financing activities	1,298,820	(446,788)
EFFECT OF EXCHANGE RATE CHANGES ON CASH	(1,420)	(16,651)
NET DECREASE IN CASH	(416,628)	(465,423)
CASH - Beginning of the period	1,048,660	497,944
CASH - End of period	632,032	32,521
SUPPLEMENTAL NONCASH INVESTING AND FINANCING ACTIVITIES:
Vehicle financing obtained	35,965	0
Purchase of prepaid insurance through assumption of note	0	36,640
Accrued IPO-related costs	0	457,298
SUPPLEMENTAL INFORMATION - Cash paid during the period for:
Income taxes	9,759	5,230
Interest	$ 109,937	$ 108,094

ORGANIZATION AND BUSINESS

ORGANIZATION AND BUSINESS	6 Months Ended
	Jun. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]	Organization and Business General – Medical Transcription Billing, Corp. (“MTBC” or the “Company”) is a healthcare information technology company that offers proprietary electronic health records and practice management solutions, together with related business services, to healthcare providers. The Company’s integrated services are designed to help customers increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs. The Company’s services include full-scale revenue cycle management, electronic health records, and other technology-driven practice management services to private and hospital-employed healthcare providers. MTBC has its corporate offices in Somerset, New Jersey and its main operating facilities in Islamabad, Pakistan and Bagh, Pakistan. The Company also has a wholly-owned subsidiary in Poland. MTBC was founded in 1999 and incorporated under the laws of the State of Delaware in 2001. MTBC Private Limited (or “MTBC Pvt. Ltd.”) is a majority-owned subsidiary of MTBC based in Pakistan and was founded in 2004. MTBC owns 99.99 0.01

BASIS OF PRESENTATION

BASIS OF PRESENTATION	6 Months Ended
	Jun. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation and Significant Accounting Policies [Text Block]	BASIS OF PRESENTATION The Company has prepared its unaudited condensed consolidated financial statements under the assumption that it is a going concern. The Company’s ability to continue as a going concern is dependent on its ability to generate sufficient cash from operations to meet its future operational cash needs and reduce the cost of U.S.-based employees, subcontractors and certain general and administrative expenses. The Company’s ability to meet its contractual obligations and remit payment under its arrangements with its vendors depends on its ability to generate positive cash flow from operations in the future, and/or securing additional financing. The Company has not yet signed any agreement that would provide for additional financing. This condition, along with certain other factors, raises substantial doubt about the Company's ability to continue as a going concern. These condensed consolidated financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern. The Company’s management has discussed options to raise additional capital through debt and equity issuances, which would allow the Company to fund future growth as well as provide additional liquidity. The Company filed a registration statement on Form S-1 with the Securities and Exchange Commission (“SEC”) on July 15, 2015 to register an offering of its preferred stock. On July 24, 2015, we received a “no-review” letter from the SEC, which means the SEC has not (and will not) review our registration statement. As a result, we believe our ability to consummate our preferred stock offering will be expedited, however, there is no assurance this offering will be successful. The Company has a line of credit with TD Bank that had a fully-utilized borrowing limit of $ 3.0 The Company has not received any indications from TD Bank that the line of credit would not be further renewed; however, if the terms of the renewal were not acceptable to the Company or the line of credit was not renewed, the Company would need to obtain additional financing. The Company believes there are several viable financing options available, including the registered preferred stock offering, although there can be no guarantee that the execution of such options would not be dilutive to existing shareholders. Management believes that MTBC will be successful in obtaining adequate sources of cash to fund its anticipated level of operations through the end of June 2016, but there can be no assurance that management will be successful in raising sufficient additional capital (including extension of the maturity dates of existing borrowings). If additional financing is not available and MTBC is unable to generate positive cash flow from operations, the Company will be compelled to reduce the scope of its business activities, including, but not limited to, the following: ⋅ Reducing the number of employees; ⋅ Reducing the number of locations that service customers; ⋅ Curtailing research and development or sales and marketing efforts; and/or ⋅ Reducing general and administrative expenses. The accompanying unaudited condensed consolidated financial statements have been prepared by MTBC in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial reporting and as required by Regulation S-X, Rule 10-01. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of the Company’s management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of items of a normal and recurring nature) necessary to present fairly the Company’s financial position as of June 30, 2015, the results of operations for the three and six months ended June 30, 2015 and 2014 and cash flows for the six months ended June 30, 2015 and 2014. The results of operations for the three and six months ended June 30, 2015 and 2014 are not necessarily indicative of the results to be expected for the full year. When preparing financial statements in conformity with GAAP, we must make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. The condensed consolidated balance sheet as of December 31, 2014 was derived from our audited consolidated financial statements. The accompanying unaudited condensed consolidated financial statements and notes thereto should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2014, which are included in the Company’s Annual Report on Form 10-K, filed with the SEC on March 31, 2015. Recent Accounting Pronouncements — From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”) and are adopted by us as of the specified effective date. Unless otherwise discussed, we believe that the impact of recently adopted and recently issued accounting pronouncements will not have a material impact on our consolidated financial position, results of operations, and cash flows. In May 2014, the FASB issued Accounting Standards Update (“ASU”) No. 2014-09 , Revenue from Contracts with Customers, In June 2014, the FASB issued guidance on stock compensation. The amendment requires that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. A reporting entity should apply existing guidance in Topic 718 as it relates to awards with performance conditions that affect vesting to account for such awards. Compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the period(s) for which the requisite service has already been rendered. The amendment is effective for annual reporting periods (including interim reporting periods within those periods) beginning after December 15, 2015. Earlier adoption is permitted. Management does not believe that the adoption of this guidance will have any material impact on the Company's condensed consolidated financial position or results of operations. In August 2014, the FASB issued ASU 2014-15, Presentation of Financial Statements-Going Concern, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern If applicable, the Company will be required to disclose (i) the principal conditions or events that raised substantial doubt about the entity’s ability to continue as a going concern (before consideration of management’s plans), (ii) management’s evaluation of the significance of those conditions or events in relation to the entity’s ability to meet its obligations, and (iii) either management’s plans that alleviated substantial doubt about the entity’s ability to continue as a going concern or management’s plans that are intended to mitigate the conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern. This standard is effective for the Company’s interim and annual consolidated financial statements for fiscal year 2017, with earlier adoption permitted. The Company is currently evaluating the impact of this new standard on its financial statements. In April 2015, the FASB issued an accounting standard that requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the debt liability rather than as an asset. Application of the standard, which is required to be applied retrospectively, is effective for fiscal years beginning on or after December 31, 2015 and for interim periods within that year. We are currently evaluating the impact of adopting this new guidance on our consolidated financial statements.

ACQUISITIONS

ACQUISITIONS	6 Months Ended
	Jun. 30, 2015
Business Combinations [Abstract]
Business Combination Disclosure [Text Block]	ACQUISITIONS On July 28, 2014, the Company completed the acquisition of three revenue cycle management companies, Omni Medical Billing Services, LLC (“Omni”), Practicare Medical Management, Inc. (“Practicare”) and CastleRock Solutions, Inc. (“CastleRock”), collectively the (“Acquired Businesses”). These acquisitions added a significant number of clients to the Company’s customer base and, similar to other acquisitions, broadened the Company’s presence in the healthcare information technology industry through geographic expansion of its customer base and by increasing available customer relationship resources and specialized trained staff. The aggregate purchase price for the Acquired Businesses amounted to approximately $ 17.4 3.89 11.4 6.0 571,000 590,302 1,699,796 6.6 The cash escrow was released 120 254,970 201,173 157,298 With respect to Omni, following the closing date an upward purchase price adjustment was made to the cash consideration payable to Omni to pay for the annualized revenue from new customers who executed one-year contracts prior to the closing, instead of the trailing 12 months’ revenue. This resulted in additional consideration of $ 100,582 15,700 The difference between the Acquired Businesses’ operating results for the period July 28 through July 31, 2014 and the amount of net funds received by the Company from the previous owners for that period was accounted for as additional purchase price and was assigned to Acquired Backlog. This intangible (approximately $ 148,000 On February 19, 2015, the Company entered into settlement agreements with certain parties that the Company believed had violated (or tortuously interfered with) an agreement restricting them from directly or indirectly soliciting customers of the Company pursuant to the acquisition agreement between the Company and CastleRock. In accordance with the settlement agreements, the Company paid $ 110,000 53,797 133,000 Under each purchase agreement, the Company may be required to issue or entitled to cancel shares issued to the Acquired Businesses in the event acquired customer revenues for the 12 months following the close are above or below a specified threshold. In the case of Practicare, the Company may also be required to make additional cash payment, in the event post-closing revenues from customers acquired exceed a specified threshold. The adjustments to the consideration for each of the Acquired Businesses will be based on the revenues generated from the acquired customers in the 12 months following the closing, as compared to the revenues generated by each of the Acquired Businesses in the four quarters ended March 31, 2014. For each of Omni and Practicare, no adjustment will be made unless the variance is greater than 10 5 For each of the Acquired Businesses, the number of shares to be cancelled or issued as applicable will be calculated using a pre-determined formula in each of the purchase agreements. As of the acquisition date, the Company recorded $ 4.4 87,000 916,000 132,879 53,797 If the performance measures required by the 2014 purchase agreements are not achieved, the Company may pay less than the recorded amount, depending on the terms of the agreement. If the price of the Company’s common stock increases, the Company may pay more than the recorded amount. Settlement will be in the form of Company’s common stock. Contingent Common Stock Acquired Consideration Total Shares Value Cash Backlog Adjustment Consideration (in thousands) Omni 1,049 $ 4,079 $ 6,655 $ 103 $ (329) $ 10,508 Practicare 293 1,137 2,394 17 (242) 3,306 CastleRock 359 1,395 2,339 28 - 3,762 Total 1,701 $ 6,611 $ 11,388 $ 148 $ (571) $ 17,576 Customer contracts and relationships $ 8,225,000 Non-compete agreements 925,000 Tangible assets 61,256 Acquired backlog 148,408 Goodwill 8,216,336 17,576,000 The weighted-average amortization period of the acquired intangible assets is 3 The fair value of the customer relationships was established using a form of the income approach known as the excess earnings method. Under the excess earnings method, value is estimated as the present value of the benefits anticipated from ownership of the subject intangible asset in excess of the returns required on the investment in the contributory assets necessary to realize those benefits. The fair value of the non-compete agreements were determined based on the difference in the expected cash flows for the business with the non-compete agreement in place and without the non-compete agreement in place. The goodwill is deductible ratably for income tax purposes over 15 The pro forma information below represents condensed consolidated results of operations as if the acquisition of the Acquired Businesses occurred on January 1, 2014. The pro forma information has been included for comparative purposes and is not indicative of results of operations of the Company had the acquisitions occurred on the above date, nor is it necessarily indicative of future results. Three Months Ended Six Months Ended June 30, 2014 June 30, 2014 In ($000s) except per share data Total revenue $ 7,762 $ 15,251 Net loss $ (841) $ (2,185) Net loss per share $ (0.16) $ (0.43)

INTANGIBLE ASSETS - NET

INTANGIBLE ASSETS - NET	6 Months Ended
	Jun. 30, 2015
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Intangible Assets Disclosure [Text Block]	4. Intangible Assets – NET June 30, December 31, 2015 2014 Contracts and relationships acquired $ 11,224,346 $ 11,164,988 Non-compete agreements 1,206,272 1,206,272 Other intangible assets 326,355 309,486 Total intangible assets 12,756,973 12,680,746 Less: Accumulated amortization (6,467,297) (4,302,909) Intangible assets - net $ 6,289,676 $ 8,377,837 Amortization expense was $ 2,163,324 434,638 1,096,576 215,704 128,000 During June 2015, the Company entered into a revenue sharing agreement with a medical billing company and purchased its customer relationships for an initial payment of $ 59,358 36 the Company is required to pay 30% of collected revenue for a period of 36 months. This obligation will be expensed as incurred. Years ending December 31 2015 (six months) $ 1,797,775 2016 3,039,545 2017 1,442,485 2018 9,871 Total $ 6,289,676

CONCENTRATIONS

CONCENTRATIONS	6 Months Ended
	Jun. 30, 2015
Risks and Uncertainties [Abstract]
Concentration Risk Disclosure [Text Block]	5. Concentrations Financial Risks — 2,682,341 26,134 56,507,436 562,823 Concentrations of credit risk with respect to trade accounts receivable are managed by periodic credit evaluations of customers. The Company does not require collateral for outstanding trade accounts receivable. No one customer accounts for a significant portion of the Company’s trade accounts receivable portfolio and write-offs have not been significant. During the three and six months ended June 30, 2015 and 2014, there were no customers with sales of 5% or more of the total. Geographical Risks — The Company’s offices in Islamabad and Bagh, Pakistan, conduct significant back-office operations for the Company. The Company has no revenue earned outside of the United States of America. The office in Bagh is located in a different territory of Pakistan from the Islamabad office. The Bagh office was opened in 2009 for the purpose of providing operational support and operating as a backup to the Islamabad office. The Company’s operations in Pakistan are subject to special considerations and significant risks not typically associated with companies in the United States. The Company’s business, financial condition and results of operations may be influenced by the political, economic, and legal environment in Pakistan and by the general state of Pakistan’s economy. The Company’s results may be adversely affected by, among other things, changes in governmental policies with respect to laws and regulations, changes in Pakistan’s telecommunications industry, regulatory rules and policies, anti-inflationary measures, currency conversion and remittance abroad, and rates and methods of taxation. The carrying amounts of net assets located in Pakistan were $ 140,339 796,609 3,893,369 2,681,937 June 30, December 31, 2015 2014 Current assets $ 158,294 $ 698,174 Non-current assets 1,332,363 1,355,333 1,490,657 2,053,507 Current liabilities (1,333,779) (1,233,618) Non-current liabilities (16,539) (23,280) $ 140,339 $ 796,609 The net assets located in Poland were not significant at June 30, 2015.

NET LOSS PER SHARE

NET LOSS PER SHARE	6 Months Ended
	Jun. 30, 2015
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	6. NET LOSS PER SHARE Three Months Ended Six Months Ended June 30, June 30, 2015 2014 2015 2014 Basic: Net loss $ (1,487,378) $ (289,401) $ (2,653,288) $ (673,073) Weighted average shares used in computing basic loss per share 9,719,858 5,101,770 9,703,568 5,101,770 Net loss per share - Basic $ (0.15) $ (0.06) $ (0.27) $ (0.13) Diluted: Net loss $ (1,487,378) $ (289,401) $ (2,653,288) $ (673,073) Weighted average shares used in computing diluted loss per share 9,719,858 5,101,770 9,703,568 5,101,770 Net loss per share - Diluted $ (0.15) $ (0.06) $ (0.27) $ (0.13) The unvested restricted share units (“RSUs”) have been excluded from the above calculation as they were anti-dilutive. Vested RSUs have been included in the above calculations. The net loss per share - basic excludes 1,287,529

DEBT

DEBT	6 Months Ended
	Jun. 30, 2015
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	7. Debt Revolving Line of Credit — November 30, 2015 3 Wall Street Journal prime rate plus 1% 4.25 3,000,000 1,215,000 Vehicle Years ending Financing Metro Loan from December 31 Notes Medical CEO Total 2015 (Six months) $ 11,240 $ 106,817 $ - $ 118,057 2016 23,718 - 470,089 493,807 2017 23,550 - - 23,550 Thereafter 28,975 - - 28,975 Total $ 87,483 $ 106,817 $ 470,089 $ 664,389

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	6 Months Ended
	Jun. 30, 2015
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	8. Commitments and Contingencies Legal Proceedings — The Company is subject to legal proceedings and claims which have arisen in the ordinary course of business and have not been fully adjudicated. These actions, when ultimately concluded and determined, will not, in the opinion of management, have a material adverse effect upon the condensed consolidated financial position, results of operations, or cash flows of the Company. At December 31, 2013, the Company had accrued a liability of $ 161,137 55,614 105,523 Leases — The Company leases certain office space and other facilities under operating leases expiring through 2021. Years Ending December 31 Total 2015 (six months) $ 265,453 2016 216,028 2017 58,500 Total $ 539,981 Total rental expense, included in direct operating costs and general and administrative expense in the condensed consolidated statements of operations, including amounts for related party leases described in Note 9, amounted to $ 426,248 233,734 179,354 128,584

RELATED PARTIES

RELATED PARTIES	6 Months Ended
	Jun. 30, 2015
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	9. Related PARTIES In February 2013, the CEO advanced a loan of $ 1,000,000 470,089 7.0 July 4, 2016 1 16,318 25,537 and $ 8,204 12,839 45,029 The Company had sales to a related party, a physician who is related to the CEO. Revenues from this customer were approximately $ 8,630 10,060 4,276 5,324 8,922 1,128 During April 2015, the Company began initial testing of a new service called Same Day Funding with the physician related to the CEO. The Audit Committee of the Board of Directors approved advancing funds of no more than $ 20,000 The Company is a party to a nonexclusive aircraft dry lease agreement with Kashmir Air, Inc. (“KAI”), which is owned by the CEO. The Company recorded expense of $ 64,200 32,100 21,852 108,902 The Company leases its corporate offices in New Jersey, its temporary housing for its foreign visitors and its backup operations center in Bagh, Pakistan, from the CEO. The related party rent expense for the six months ended June 30, 2015 and 2014 was $ 87,541 85,007 43,743 42,787 13,200 11,084 The Company advanced $ 1,000 The CEO of the Company has guaranteed the Company’s existing line of credit with the TD Bank.

EMPLOYEE BENEFIT PLANS

EMPLOYEE BENEFIT PLANS	6 Months Ended
	Jun. 30, 2015
Compensation and Retirement Disclosure [Abstract]
Pension and Other Postretirement Benefits Disclosure [Text Block]	Employee Benefit PlanS The Company has a qualified 401(k) plan covering all U.S. employees who have completed three months of service. The plan provides for matching contributions by the Company equal to 100 3 50 2 48,360 27,049 24,798 11,969 Additionally, the Company has a defined contribution retirement plan covering all employees located in Pakistan who have completed 90 days of service. The plan provides for monthly contributions by the Company which are the lower of 10 750 56,919 43,061

STOCK-BASED COMPENSATION

STOCK-BASED COMPENSATION	6 Months Ended
	Jun. 30, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	11. STOCK-BASED COMPENSATION In April 2014, the Company adopted the Medical Transcription Billing, Corp. 2014 Equity Incentive Plan (the “2014 Plan”), reserving a total of 1,351,000 737,625 Three Months Ended Six Months Ended June 30, 2015 June 30, 2015 Stock-based compensation included in the Condensed Consolidated Statement of Operations: Direct operating costs $ 7,364 $ 12,113 General and administrative 177,178 298,298 Research and development 12,592 13,847 Total stock-based compensation expense $ 197,134 $ 324,258 The stock-based compensation included in the Condensed Consolidated Statement of Operations for the three and six months ended June 30, 2014 was $ 62,514 RSUs outstanding and unvested at January 1, 2014 - RSUs granted 513,500 RSUs vested - RSUs forfeited (31,250) RSUs outstanding and unvested at December 31, 2014 482,250 RSUs granted 221,600 RSUs vested (72,500) RSUs forfeited (90,475) RSUs outstanding and unvested at June 30, 2015 540,875

INCOME TAXES

INCOME TAXES	6 Months Ended
	Jun. 30, 2015
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	12. INCOME TAXES Due to the valuation allowance previously recorded against all net deferred tax assets, no income tax benefit was recorded for the three and six months ended June 30, 2015. The provision for the three and six months ended June 30, 2015 represents state minimum taxes and taxes attributable to Pakistan. For the three and six months ended June 30, 2014, we used a discrete approach in calculating the tax benefit. Under the discrete method, we determined our tax benefit based upon actual results as if the interim period were an annual period. The Company’s plan to repatriate earnings in Pakistan to the United States requires that U.S. Federal taxes be provided on the Company’s earnings in Pakistan. For state tax purposes, the Company’s Pakistan earnings generally are not taxed due to a subtraction modification available in most states. Although the Company is forecasting a return to profitability, it incurred cumulative losses which make realization of a deferred tax asset difficult to support in accordance with Accounting Standards Codification (“ASC”) 740. Accordingly, a valuation allowance has been recorded against all Federal and state deferred tax assets as of June 30, 2015 and December 31, 2014.

OTHER INCOME (EXPENSE) - NET

OTHER INCOME (EXPENSE) - NET	6 Months Ended
	Jun. 30, 2015
Other Income and Expenses [Abstract]
Other Nonoperating Income and Expense [Text Block]	13. OTHER INCOME (EXPENSE) – NET Three Months Ended Six Months Ended June 30, June 30, 2015 2014 2015 2014 Foreign exchange gain (loss) 45,547 19,288 77,020 $ (183,976) Other 11,666 (1,557) 26,339 1,822 Other income (expense) - net $ 57,213 $ 17,731 $ 103,359 $ (182,154) Foreign currency transaction gains (losses) result from transactions related to the intercompany receivable for which transaction adjustments are recorded in the condensed consolidated statements of operations as they are not deemed to be permanently reinvested. An increase in the exchange rate of Pakistan rupees per U.S. dollar by 1 45,547 77,020 6 19,288 183,976

FAIR VALUE OF FINANCIAL INSTRUM

FAIR VALUE OF FINANCIAL INSTRUMENTS	6 Months Ended
	Jun. 30, 2015
Fair Value Disclosures [Abstract]
Fair Value Disclosures [Text Block]	14. FAIR VALUE OF FINANCIAL INSTRUMENTS As of June 30, 2015 and December 31, 2014, the carrying amounts of cash, receivables, and accounts payable and accrued expenses approximated their estimated fair values because of the short term nature of these financial instruments. Our long-term debt and notes payable are carried at cost and approximate fair value since the interest rate being charged approximates market rates. The fair value of related party transactions including the note payable to the CEO cannot be determined based upon the related party nature of the transactions. (See Note 15.) Contingent Consideration The Company’s potential contingent considerations of $ 1,843,387 2,626,323 March 31, 2014 0.02 Fair Value Measurement at Balance - January 1, 2015 $ 2,626,323 Change in fair value (782,936) Balance - June 30, 2015 $ 1,843,387

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Jun. 30, 2015
Subsequent Events [Abstract]
Subsequent Events [Text Block]	SUBSEQUENT EVENTS On July 13, 2015, the Company amended and restated its promissory note to its CEO. The amended and restated note amends, restates and replaces the obligation under the Company’s original promissory note to the CEO dated July 5, 2013, as amended, which was made in the amount of $ 1,000,000 The amended and restated note allows, upon mutual content of the CEO and the Company, the re-borrowing by the Company of sums which have been prepaid under the amended and restated note as long as the total amount outstanding at any time does not exceed $ 1,000,000 410,000 On July 10, 2015 the Company entered into an asset purchase agreement with SoftCare Solutions, Inc. a Nevada Corporation (“SoftCare”), the U.S. subsidiary of QHR Corporation, a Canada-based healthcare technology Company (“QHR”). Pursuant to this agreement, the Company purchased assets relating to SoftCare’s clearinghouse, healthcare electronic data interchange (EDI), and billing divisions The Company paid $ 21,888 38,127 the Company will pay QHR an amount equal to 5% of the gross fees earned and received by the Company from the acquired customers during the 12 month period beginning on the second anniversary of the acquisition’s closing date. 260,000 The Company has agreed to pay QHR 50% of any such amount collected The above acquisition will be recorded as a business combination which will include the contingent consideration.

ACQUISITIONS (Tables)

ACQUISITIONS (Tables) - Acquired Businesses [Member]	6 Months Ended
	Jun. 30, 2015
Business Combinations [Abstract]
Schedule of Business Acquisitions, by Acquisition [Table Text Block]	The following table summarizes the final purchase price consideration and the allocation of the purchase price to the net assets acquired: Contingent Common Stock Acquired Consideration Total Shares Value Cash Backlog Adjustment Consideration (in thousands) Omni 1,049 $ 4,079 $ 6,655 $ 103 $ (329) $ 10,508 Practicare 293 1,137 2,394 17 (242) 3,306 CastleRock 359 1,395 2,339 28 - 3,762 Total 1,701 $ 6,611 $ 11,388 $ 148 $ (571) $ 17,576
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	The results of the valuation analysis are presented below: Customer contracts and relationships $ 8,225,000 Non-compete agreements 925,000 Tangible assets 61,256 Acquired backlog 148,408 Goodwill 8,216,336 17,576,000
Business Acquisition, Pro Forma Information [Table Text Block]	Three Months Ended Six Months Ended June 30, 2014 June 30, 2014 In ($000s) except per share data Total revenue $ 7,762 $ 15,251 Net loss $ (841) $ (2,185) Net loss per share $ (0.16) $ (0.43)

INTANGIBLE ASSETS - NET (Tables

INTANGIBLE ASSETS - NET (Tables)	6 Months Ended
	Jun. 30, 2015
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Schedule of Finite-Lived Intangible Assets [Table Text Block]	Intangible assets-net as of June 30, 2015 and December 31, 2014 consist of following: June 30, December 31, 2015 2014 Contracts and relationships acquired $ 11,224,346 $ 11,164,988 Non-compete agreements 1,206,272 1,206,272 Other intangible assets 326,355 309,486 Total intangible assets 12,756,973 12,680,746 Less: Accumulated amortization (6,467,297) (4,302,909) Intangible assets - net $ 6,289,676 $ 8,377,837
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	As of June 30, 2015, future amortization expense scheduled to be expensed is as follows: Years ending December 31 2015 (six months) $ 1,797,775 2016 3,039,545 2017 1,442,485 2018 9,871 Total $ 6,289,676

CONCENTRATIONS (Tables)

CONCENTRATIONS (Tables)	6 Months Ended
	Jun. 30, 2015
Risks and Uncertainties [Abstract]
Schedules of Concentration of Risk, by Geographical Risks Factor [Table Text Block]	The following is a summary of the net assets located in Pakistan as of June 30, 2015 and December 31, 2014: June 30, December 31, 2015 2014 Current assets $ 158,294 $ 698,174 Non-current assets 1,332,363 1,355,333 1,490,657 2,053,507 Current liabilities (1,333,779) (1,233,618) Non-current liabilities (16,539) (23,280) $ 140,339 $ 796,609

NET LOSS PER SHARE (Tables)

NET LOSS PER SHARE (Tables)	6 Months Ended
	Jun. 30, 2015
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	The following table reconciles the weighted-average shares outstanding for basic and diluted net loss per share for the three and six months ended June 30, 2015 and 2014: Three Months Ended Six Months Ended June 30, June 30, 2015 2014 2015 2014 Basic: Net loss $ (1,487,378) $ (289,401) $ (2,653,288) $ (673,073) Weighted average shares used in computing basic loss per share 9,719,858 5,101,770 9,703,568 5,101,770 Net loss per share - Basic $ (0.15) $ (0.06) $ (0.27) $ (0.13) Diluted: Net loss $ (1,487,378) $ (289,401) $ (2,653,288) $ (673,073) Weighted average shares used in computing diluted loss per share 9,719,858 5,101,770 9,703,568 5,101,770 Net loss per share - Diluted $ (0.15) $ (0.06) $ (0.27) $ (0.13)

DEBT (Tables)

DEBT (Tables)	6 Months Ended
	Jun. 30, 2015
Debt Disclosure [Abstract]
Schedule of Maturities of Long-term Debt [Table Text Block]	Maturities of notes payable as of June 30, 2015 are as follows: Vehicle Years ending Financing Metro Loan from December 31 Notes Medical CEO Total 2015 (Six months) $ 11,240 $ 106,817 $ - $ 118,057 2016 23,718 - 470,089 493,807 2017 23,550 - - 23,550 Thereafter 28,975 - - 28,975 Total $ 87,483 $ 106,817 $ 470,089 $ 664,389

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	6 Months Ended
	Jun. 30, 2015
Commitments and Contingencies Disclosure [Abstract]
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	Future minimum lease payments under non-cancelable operating leases with related parties and for office space as of June 30, 2015 are as follows (certain leases with non-related parties are cancellable): Years Ending December 31 Total 2015 (six months) $ 265,453 2016 216,028 2017 58,500 Total $ 539,981

STOCK-BASED COMPENSATION (Table

STOCK-BASED COMPENSATION (Tables)	6 Months Ended
	Jun. 30, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]	Three Months Ended Six Months Ended June 30, 2015 June 30, 2015 Stock-based compensation included in the Condensed Consolidated Statement of Operations: Direct operating costs $ 7,364 $ 12,113 General and administrative 177,178 298,298 Research and development 12,592 13,847 Total stock-based compensation expense $ 197,134 $ 324,258
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]	The following table summarizes the RSU transactions under the 2014 Plan for the year ended December 31, 2014 and the six months ended June 30, 2015: RSUs outstanding and unvested at January 1, 2014 - RSUs granted 513,500 RSUs vested - RSUs forfeited (31,250) RSUs outstanding and unvested at December 31, 2014 482,250 RSUs granted 221,600 RSUs vested (72,500) RSUs forfeited (90,475) RSUs outstanding and unvested at June 30, 2015 540,875

OTHER INCOME (EXPENSE) - NET (T

OTHER INCOME (EXPENSE) - NET (Tables)	6 Months Ended
	Jun. 30, 2015
Other Income and Expenses [Abstract]
Schedule of Other Nonoperating Income (Expense) [Table Text Block]	Other income (expense)-net for the three and six months ended June 30, 2015 and 2014 consisted of the following: Three Months Ended Six Months Ended June 30, June 30, 2015 2014 2015 2014 Foreign exchange gain (loss) 45,547 19,288 77,020 $ (183,976) Other 11,666 (1,557) 26,339 1,822 Other income (expense) - net $ 57,213 $ 17,731 $ 103,359 $ (182,154)

FAIR VALUE OF FINANCIAL INSTR32

FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)	6 Months Ended
	Jun. 30, 2015
Fair Value Disclosures [Abstract]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	The following table provides a reconciliation of the beginning and ending balances for the contingent consideration measured at fair value using significant unobservable inputs (Level 3): Fair Value Measurement at Balance - January 1, 2015 $ 2,626,323 Change in fair value (782,936) Balance - June 30, 2015 $ 1,843,387

ORGANIZATION AND BUSINESS (Deta

ORGANIZATION AND BUSINESS (Details Textual)	Jun. 30, 2015
Description of Business [Line Items]
Equity Method Investment, Ownership Percentage	99.99%
Chief Executive Officer [Member]
Description of Business [Line Items]
Equity Method Investment, Ownership Percentage	0.01%

BASIS OF PRESENTATION (Details

BASIS OF PRESENTATION (Details Textual) $ in Millions	Jun. 30, 2015USD ($)
Investor [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 3

ACQUISITIONS (Details)

ACQUISITIONS (Details) - 6 months ended Jun. 30, 2015 - USD ($) shares in Thousands, $ in Thousands	Total
Business Acquisition [Line Items]
Purchase price consideration, Cash	$ 11,388
Purchase price consideration, Acquired Backlog	148
Purchase price consideration, Contingent Consideration Adjustment	(571)
Purchase price consideration, Total Consideration	$ 17,576
Common Stock [Member]
Business Acquisition [Line Items]
Purchase price consideration, Shares	1,701
Purchase price consideration, Value	$ 6,611
Omni [Member]
Business Acquisition [Line Items]
Purchase price consideration, Cash	6,655
Purchase price consideration, Acquired Backlog	103
Purchase price consideration, Contingent Consideration Adjustment	(329)
Purchase price consideration, Total Consideration	$ 10,508
Omni [Member] | Common Stock [Member]
Business Acquisition [Line Items]
Purchase price consideration, Shares	1,049
Purchase price consideration, Value	$ 4,079
Practicare [Member]
Business Acquisition [Line Items]
Purchase price consideration, Cash	2,394
Purchase price consideration, Acquired Backlog	17
Purchase price consideration, Contingent Consideration Adjustment	(242)
Purchase price consideration, Total Consideration	$ 3,306
Practicare [Member] | Common Stock [Member]
Business Acquisition [Line Items]
Purchase price consideration, Shares	293
Purchase price consideration, Value	$ 1,137
CastleRock [Member]
Business Acquisition [Line Items]
Purchase price consideration, Cash	2,339
Purchase price consideration, Acquired Backlog	28
Purchase price consideration, Contingent Consideration Adjustment	0
Purchase price consideration, Total Consideration	$ 3,762
CastleRock [Member] | Common Stock [Member]
Business Acquisition [Line Items]
Purchase price consideration, Shares	359
Purchase price consideration, Value	$ 1,395

ACQUISITIONS (Details 1)

ACQUISITIONS (Details 1)	Jun. 30, 2015USD ($)
Business Acquisition [Line Items]
Customer contracts and relationships	$ 8,225,000
Non-compete agreements	925,000
Tangible assets	61,256
Acquired backlog	148,408
Goodwill	8,216,336
Total	$ 17,576,000

ACQUISITIONS (Details 2)

ACQUISITIONS (Details 2) - Jun. 30, 2014 - Medical Transcription Billing, Corp. [Member] - USD ($) $ / shares in Units, $ in Thousands	Total	Total
Business Acquisition [Line Items]
Total revenue	$ 7,762	$ 15,251
Net loss	$ (841)	$ (2,185)
Net loss per share	$ (0.16)	$ (0.43)

ACQUISITIONS (Details Textual)

ACQUISITIONS (Details Textual) - USD ($)	1 Months Ended	3 Months Ended		6 Months Ended		12 Months Ended
	Feb. 28, 2015	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014
Business Acquisition [Line Items]
Payments to Acquire Businesses, Gross				$ 11,388,000
Business Combination, Contingent Consideration, Liability		$ 4,400,000		4,400,000
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability		$ (87,054)	$ 0	$ (915,815)	$ 0
Escrow Deposit Duration				120 days
Settlement Payments				$ 110,000	$ 0
Settlement Gain For The Fair Value During The Period				$ 133,000
Other Intangible Assets [Member]
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life				3 years
Stock Forfeiture Gain [Member]
Business Acquisition [Line Items]
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability				$ 132,879
Equity Issued in Business Combination [Member]
Business Acquisition [Line Items]
Equity, Fair Value Adjustment				571,000
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable				$ 6,600,000
Common Stock [Member]
Business Acquisition [Line Items]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares				1,699,796
Stock Issued During Period Shares Acquisitions, Forfeited				53,797
Acquired Businesses [Member]
Business Acquisition [Line Items]
Business Acquisition, Share Price		$ 3.89		$ 3.89
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned		$ 6,000,000		$ 6,000,000
Escrow Deposit		590,302		590,302
Payments to Acquire Businesses, Gross				11,400,000
Amortization of Acquisition Costs						$ 148,000
Business Acquisition, Purchase Price		$ 17,400,000		$ 17,400,000
Stock Issued During Period Shares Acquisitions, Forfeited				53,797
Acquired Businesses [Member] | Equity Issued in Business Combination [Member]
Business Acquisition [Line Items]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	201,173
Acquired Businesses [Member] | Goodwill [Member]
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life				15 years
Acquired Businesses [Member] | Shares will be Released After Six Months [Member]
Business Acquisition [Line Items]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares				254,970
Acquired Businesses [Member] | Shares will be Released After Nine Months [Member]
Business Acquisition [Line Items]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares				157,298
Omni Medical Billing Services, LLC [Member]
Business Acquisition [Line Items]
Payments to Acquire Businesses, Gross				$ 6,655,000
Percentage of Minimum Variance for Upward Purchase Price Adjustment		10.00%		10.00%
Omni Medical Billing Services, LLC [Member] | Upward Purchase Price Adjustment [Member]
Business Acquisition [Line Items]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares				15,700
Payments to Acquire Businesses, Gross				$ 100,582
Practicare Medical Management, Inc. [Member]
Business Acquisition [Line Items]
Payments to Acquire Businesses, Gross				$ 2,394,000
Percentage of Minimum Variance for Upward Purchase Price Adjustment		5.00%		5.00%
CastleRock Solutions, Inc. [Member]
Business Acquisition [Line Items]
Payments to Acquire Businesses, Gross				$ 2,339,000
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability		$ 87,000		$ 916,000
Business Acquisition, Equity interest forfeited, Number of Shares				53,797

INTANGIBLE ASSETS - NET (Detail

INTANGIBLE ASSETS - NET (Details) - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Finite-Lived Intangible Assets [Line Items]
Contracts and relationships acquired	$ 11,224,346	$ 11,164,988
Non-compete agreements	1,206,272	1,206,272
Other intangible assets	326,355	309,486
Total intangible assets	12,756,973	12,680,746
Less: Accumulated amortization	(6,467,297)	(4,302,909)
Intangible assets - net	$ 6,289,676	$ 8,377,837

INTANGIBLE ASSETS - NET (Deta40

INTANGIBLE ASSETS - NET (Details 1) - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Years ending, December 31
2015 (six months)	$ 1,797,775
2,016	3,039,545
2,017	1,442,485
2,018	9,871
Total	$ 6,289,676	$ 8,377,837

INTANGIBLE ASSETS - NET (Deta41

INTANGIBLE ASSETS - NET (Details Textual) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Finite-Lived Intangible Assets [Line Items]
Amortization of Intangible Assets	$ 1,096,576	$ 215,704	$ 2,163,324	$ 434,638
Finite-Lived Intangible Assets, Remaining Amortization Period			3 years
Amortization, Total	$ 128,000
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Payments to Acquire Intangible Assets			$ 59,358
Terms of Revenue Sharing Relationships			the Company is required to pay 30% of collected revenue for a period of 36 months. This obligation will be expensed as incurred.
Finite-Lived Intangible Assets, Expected Amortization Period			36 months

CONCENTRATIONS (Details)

CONCENTRATIONS (Details) - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Unusual Risk or Uncertainty [Line Items]
Current assets	$ 3,673,974	$ 4,584,700
Assets	20,153,284	23,107,260
Current liabilities	(7,396,399)	(8,144,125)
Subsidiary in Pakistan [Member]
Unusual Risk or Uncertainty [Line Items]
Current assets	158,294	698,174
Non-current assets	1,332,363	1,355,333
Assets	1,490,657	2,053,507
Current liabilities	(1,333,779)	(1,233,618)
Non-current liabilities	(16,539)	(23,280)
Net assets	$ 140,339	$ 796,609

CONCENTRATIONS (Details Textual

CONCENTRATIONS (Details Textual)	6 Months Ended
	Jun. 30, 2015USD ($)	Jun. 30, 2015PKR	Dec. 31, 2014USD ($)	Dec. 31, 2014PKR
Unusual Risk or Uncertainty [Line Items]
Fair Value, Concentration of Risk, Cash and Cash Equivalents	$ 26,134		$ 562,823
Concentration Risk, Percentage	5.00%
Subsidiary in Pakistan [Member]
Unusual Risk or Uncertainty [Line Items]
Fair Value, Concentration of Risk, Cash and Cash Equivalents | PKR		PKR 2,682,341		PKR 56,507,436
Intercompany Receivables	$ 3,893,369		2,681,937
Net Assets	$ 140,339		$ 796,609

NET LOSS PER SHARE (Details)

NET LOSS PER SHARE (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Basic:
Net loss	$ (1,487,378)	$ (289,401)	$ (2,653,288)	$ (673,073)
Weighted average shares used in computing basic loss per share	9,719,858	5,101,770	9,703,568	5,101,770
Net loss per share - Basic	$ (0.15)	$ (0.06)	$ (0.27)	$ (0.13)
Diluted:
Net loss	$ (1,487,378)	$ (289,401)	$ (2,653,288)	$ (673,073)
Weighted average shares used in computing diluted loss per share	9,719,858	5,101,770	9,703,568	5,101,770
Net loss per share - Diluted	$ (0.15)	$ (0.06)	$ (0.27)	$ (0.13)

NET LOSS PER SHARE (Details Tex

NET LOSS PER SHARE (Details Textual)	6 Months Ended
	Jun. 30, 2015shares
Earnings Per Share [Line Items]
Contingently Shares Issued	1,287,529

DEBT (Details)

DEBT (Details)	Jun. 30, 2015USD ($)
Year Ending December 31
2015 (Six months)	$ 118,057
2,016	493,807
2,017	23,550
Thereafter	28,975
Total	664,389
Vehicle Financing Notes [Member]
Year Ending December 31
2015 (Six months)	11,240
2,016	23,718
2,017	23,550
Thereafter	28,975
Total	87,483
Loan from Metro Medical [Member]
Year Ending December 31
2015 (Six months)	106,817
2,016	0
2,017	0
Thereafter	0
Total	106,817
Loan from CEO [Member]
Year Ending December 31
2015 (Six months)	0
2,016	470,089
2,017	0
Thereafter	0
Total	$ 470,089

DEBT (Details Textual)

DEBT (Details Textual) - TD Bank [Member] - USD ($)	6 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 3,000,000
Line of Credit Facility, Interest Rate Description	Wall Street Journal prime rate plus 1%
Line of Credit Facility, Interest Rate at Period End	4.25%	4.25%
Line of Credit	$ 3,000,000	$ 1,215,000
Line of Credit Facility, Expiration Date	Nov. 30, 2015

COMMITMENTS AND CONTINGENCIES48

COMMITMENTS AND CONTINGENCIES (Details)	Jun. 30, 2015USD ($)
Years Ending, December 31:
2015 (six months)	$ 265,453
2,016	216,028
2,017	58,500
Total	$ 539,981

COMMITMENTS AND CONTINGENCIES49

COMMITMENTS AND CONTINGENCIES (Details Textual) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2013
Direct Operating Costs and General and Administrative Expense [Member]
Operating Leased Assets [Line Items]
Operating Leases, Rent Expense	$ 179,354	$ 128,584	$ 426,248	$ 233,734
Sonix Medical Technologies, Inc. [Member]
Operating Leased Assets [Line Items]
Settlement Liabilities, Current		$ 55,614		55,614
Sonix Medical Technologies, Inc. [Member] | General and Administrative Expense [Member]
Operating Leased Assets [Line Items]
Decrease (Increase) in Accrued Liabilities				$ 105,523
Sonix Medical Technologies, Inc. [Member] | Other Current Liabilities [Member]
Operating Leased Assets [Line Items]
Referral Fee Payable					$ 161,137

RELATED PARTIES (Details Textua

RELATED PARTIES (Details Textual) - USD ($)	1 Months Ended	3 Months Ended			6 Months Ended
	Apr. 30, 2015	Jun. 30, 2015	Jun. 30, 2014	Mar. 31, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014
Related Party Transaction [Line Items]
Notes Payable, Related Parties, Current		$ 0			$ 0		$ 470,089
Payments to Fund Long-term Loans to Related Parties					$ 0	$ 2,522
Debt Instrument, Maturity Date					Jul. 4, 2016
Physician [Member]
Related Party Transaction [Line Items]
Accounts Receivable, Related Parties, Current		8,922			$ 8,922		1,128
Revenues		4,276	$ 5,324		8,630	10,060
Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Debt Instrument, Face Amount		1,000,000			1,000,000		1,000,000
Interest Expense, Debt		8,204	12,839		16,318	25,537
Interest Paid					45,029
Notes Payable, Related Parties, Current		$ 470,089			$ 470,089		470,089
Payments to Fund Long-term Loans to Related Parties				$ 1,000
Security Deposit							$ 13,200
Debt Instrument, Interest Rate, Stated Percentage		7.00%			7.00%		7.00%
Prepaid Rent							$ 11,084
Operating Leases, Rent Expense		$ 43,743	42,787		$ 87,541	85,007
Chief Executive Officer [Member] | Subsequent Event [Member]
Related Party Transaction [Line Items]
Debt Instrument, Repurchased Face Amount		1,000,000			1,000,000
Chief Executive Officer [Member] | Maximum [Member]
Related Party Transaction [Line Items]
Advance Funds Approved	$ 20,000
Kashmir Air, Inc [Member]
Related Party Transaction [Line Items]
Operating Leases, Rent Expense		32,100	$ 32,100		64,200	$ 64,200
Due to Related Parties		$ 21,852			$ 21,852		$ 108,902

EMPLOYEE BENEFIT PLANS (Details

EMPLOYEE BENEFIT PLANS (Details Textual)	3 Months Ended		6 Months Ended
	Jun. 30, 2015USD ($)	Jun. 30, 2014USD ($)	Jun. 30, 2015USD ($)	Jun. 30, 2015PKR	Jun. 30, 2014USD ($)
United States Postretirement Benefit Plan of US Entity [Member]
Defined Contribution Plan Disclosure [Line Items]
Defined Benefit Plan, Contributions by Employer	$ 24,798	$ 11,969	$ 48,360		$ 27,049
PK [Member] | Domestic Postretirement Benefit Plan of Foreign Entity [Member]
Defined Contribution Plan Disclosure [Line Items]
Defined Benefit Plan, Contributions by Employer	$ 29,214	$ 22,788	$ 56,919		$ 43,061
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent			10.00%	10.00%
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Amount | PKR				PKR 750
Qualified Compensation Deferred Plan [Member] | United States Postretirement Benefit Plan of US Entity [Member]
Defined Contribution Plan Disclosure [Line Items]
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay			100.00%	100.00%
Defined Contribution Plan, Employer Matching Contribution, Percent of Match			3.00%	3.00%
Deferred Plan [Member] | United States Postretirement Benefit Plan of US Entity [Member]
Defined Contribution Plan Disclosure [Line Items]
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay			50.00%	50.00%
Defined Contribution Plan, Employer Matching Contribution, Percent of Match			2.00%	2.00%

STOCK-BASED COMPENSATION (Detai

STOCK-BASED COMPENSATION (Details) - Jun. 30, 2015 - USD ($)	Total	Total
Stock-based compensation charged to Condensed Consolidated Statement of Income:
Allocated Share-based Compensation Expense	$ 197,134	$ 324,258
Direct operating costs [Member]
Stock-based compensation charged to Condensed Consolidated Statement of Income:
Allocated Share-based Compensation Expense	7,364	12,113
General and Administrative [Member]
Stock-based compensation charged to Condensed Consolidated Statement of Income:
Allocated Share-based Compensation Expense	177,178	298,298
Research and Development Expense [Member]
Stock-based compensation charged to Condensed Consolidated Statement of Income:
Allocated Share-based Compensation Expense	$ 12,592	$ 13,847

STOCK-BASED COMPENSATION (Det53

STOCK-BASED COMPENSATION (Details 1) - Restricted Stock Units (RSUs) [Member] - shares	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
RSUs outstanding and unvested at beginning balance	482,250	0
RSUs granted	221,600	513,500
RSUs vested	(72,500)	0
RSUs forfeited	(90,475)	(31,250)
RSUs outstanding and unvested at ending balance	540,875	482,250

STOCK-BASED COMPENSATION (Det54

STOCK-BASED COMPENSATION (Details Textual) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Apr. 30, 2014
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Allocated Share-based Compensation Expense	$ 197,134		$ 324,258
Operating Income (Loss) [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Allocated Share-based Compensation Expense		$ 62,514		$ 62,514
2014 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized					1,351,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	737,625		737,625

OTHER INCOME (EXPENSE) - NET (D

OTHER INCOME (EXPENSE) - NET (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Other Income and Expense [Line Items]
Foreign exchange gain (loss)	$ 45,547	$ 19,288	$ 77,020	$ (183,976)
Other	11,666	(1,557)	26,339	1,822
Other income (expense) - net	$ 57,213	$ 17,731	$ 103,359	$ (182,154)

OTHER INCOME (EXPENSE) - NET 56

OTHER INCOME (EXPENSE) - NET (Details Textual) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Other Income and Expense [Line Items]
Percentage of Increase (Decrease) in Foreign Currency Exchange Rate			1.00%	6.00%
Foreign Currency Transaction Gain (Loss), before Tax	$ 45,547	$ 19,288	$ 77,020	$ (183,976)

FAIR VALUE OF FINANCIAL INSTR57

FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - Fair Value, Output, Level 3 [Member]	6 Months Ended
	Jun. 30, 2015USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance - January 1, 2015	$ 2,626,323
Change in fair value	(782,936)
Balance - June 30, 2015	$ 1,843,387

FAIR VALUE OF FINANCIAL INSTR58

FAIR VALUE OF FINANCIAL INSTRUMENTS (Details Textual) - USD ($)	6 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Business Combination, Contingent Consideration, Liability, Current	$ 1,843,387	$ 2,626,323
Bond Yield To Estimated Discounted Rate	0.02%
Acquisitions 2014 [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Business Combination, Contingent Consideration, Liability, Current	$ 1,843,387	$ 2,626,323

SUBSEQUENT EVENTS (Details Text

SUBSEQUENT EVENTS (Details Textual) - Jun. 30, 2015 - Subsequent Event [Member] - USD ($)	Total
Subsequent Event [Line Items]
Business Combination, Contingent Consideration Arrangements, Description	The Company has agreed to pay QHR 50% of any such amount collected
Business Combination, Contingent Consideration Arrangements, Basis for Amount	which represented 5% of the trailing 12 months revenue generated by the acquired customers of the Divisions
For Three Years [Member]
Subsequent Event [Line Items]
Business Combination, Contingent Consideration Arrangements, Description	the Company will pay QHR 30% of the gross fees earned and collected from the acquired customers
Other Commitments, Description	the Company will pay QHR an amount equal to 5% of the gross fees earned and received by the Company from the acquired customers during the 12 month period beginning on the second anniversary of the acquisitions closing date.
Chief Executive Officer [Member]
Subsequent Event [Line Items]
Debt Instrument, Face Amount	$ 1,000,000
Debt Instrument, Repurchased Face Amount	1,000,000
Proceeds from Issuance of Debt	410,000
Acquired Customers [Member]
Subsequent Event [Line Items]
Payments for Purchase of Other Assets	21,888
Adjustment On Payment of Assets Purchases	38,127
QHR Corporation [Member]
Subsequent Event [Line Items]
Accounts Receivable, Related Parties	$ 260,000